SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-092814
Filing Date
2023-12-04
Accepted
2023-12-04 17:26:05
Documents
16
Period of Report
2023-12-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea189274-8k_tffpharm.htm   iXBRL 8-K 27689
2 PRESS RELEASE ANNOUNCING THE APPOINTMENT OF CATHERINE LEE TO THE TFF BOARD ea189274ex99-1_tffpharm.htm EX-99.1 13553
3 PRESS RELEASE ANNOUNCING THE APPOINTMENT OF MICHAEL PATANE TO THE TFF BOARD ea189274ex99-2_tffpharm.htm EX-99.2 13678
4 GRAPHIC ex99-1_001.jpg GRAPHIC 3561
5 GRAPHIC ex99-2_001.jpg GRAPHIC 3561
  Complete submission text file 0001213900-23-092814.txt   251640

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE tffp-20231201.xsd EX-101.SCH 3018
7 XBRL LABEL FILE tffp-20231201_lab.xml EX-101.LAB 34240
8 XBRL PRESENTATION FILE tffp-20231201_pre.xml EX-101.PRE 22361
10 EXTRACTED XBRL INSTANCE DOCUMENT ea189274-8k_tffpharm_htm.xml XML 3408
Mailing Address 2600 VIA FORTUNA, SUITE 360 AUSTIN TX 78746
Business Address 2600 VIA FORTUNA, SUITE 360 AUSTIN TX 78746 737-802-1973
TFF Pharmaceuticals, Inc. (Filer) CIK: 0001733413 (see all company filings)

IRS No.: 824344737 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39102 | Film No.: 231464443
SIC: 2834 Pharmaceutical Preparations